My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Skye Bioscience, Inc. - Common Stock (NQ:SKYE)

1.310 +0.030 (+2.34%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Skye Bioscience, Inc. - Common Stock

< Previous 1 2 3 Next >

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE

November 26, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SKYE

November 26, 2025

From The DJS Law Group

Via Business Wire

SKYE Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the Skye Bioscience, Inc. Class Action Lawsuit

November 25, 2025

From Robbins LLP

Via GlobeNewswire

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm

November 25, 2025

From Schall Law

Via GlobeNewswire

Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your Rights - SKYE

November 25, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your Rights - SKYE

November 25, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Bragar Eagel & Squire, P.C. Reminds Stockholders Spirit, Molina, Skye, and Perrigo of the Upcoming Deadlines and Urges Investors to Contact the Firm

November 24, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Lost Money on Skye Bioscience, Inc. (SKYE)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

November 24, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Lost Money on Skye Bioscience, Inc. (SKYE)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

November 24, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Skye Bioscience to Participate in Upcoming Investment Conferences

November 24, 2025

San Diego, California--(Newsfile Corp. - November 24, 2025) - Skye Bioscience, Inc. (NASDAQ: SKYE) ("Skye"), a clinical-stage biotechnology company focused...

Via Newsfile

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm

November 21, 2025

From Schall Law

Via GlobeNewswire

SKYE INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience

November 20, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Skye Bioscience and Perrigo and Encourages Investors to Contact the Firm

November 18, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit With the Schall Law Firm

November 18, 2025

From The Schall Law Firm

Via Business Wire

SKYE Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against Skye Bioscience, Inc.

November 18, 2025

From Robbins LLP

Via GlobeNewswire

5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity? ↗

November 18, 2025

One major biotech investor just walked away from Viking Therapeutics. Here’s what the move may—and may not—mean for the company’s clinical-stage future.

Via The Motley Fool

Topics Regulatory Compliance

5AM Venture Bails on MoonLake After a Brutal Year: Here’s What Stands Out ↗

November 18, 2025

A major biotech investor just walked away from MoonLake after a rough year for the stock. Here’s what that move signals—and what long-term investors should keep an eye on next.

Via The Motley Fool

Rosen Law Firm Urges Skye Bioscience, Inc. (NASDAQ: SKYE) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

November 18, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

Insights Ahead: Skye Bioscience's Quarterly Earnings ↗

November 07, 2025

Via Benzinga

The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things. ↗

November 07, 2025

The feast that saw obesity-tied stocks skyrocket in 2024 is over. Investors' appetite for weight-loss drugs has waned.

Via Investor's Business Daily

Topics Government

These stocks are moving in today's session ↗

October 06, 2025

Here are the top movers in Monday's session, showcasing the stocks with significant price changes.

Via Chartmill

Nasdaq Jumps Over 150 Points; Skye Bioscience Shares Plunge ↗

October 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 06, 2025

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

October 06, 2025

Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

US Stocks Mixed; Dow Falls 100 Points ↗

October 06, 2025

Via Benzinga

Topics Stocks

Skye Bioscience's Investigational Drug Disappoints As Monotherapy For Weight Loss ↗

October 06, 2025

Skye Bioscience'a trial showed nimacimab alone missed goals, while a combo with Novo Nordisk's drug delivered stronger weight loss results.

Via Benzinga

Monday's session: gap up and gap down stocks ↗

October 06, 2025

The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

Why AMD Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket ↗

October 06, 2025

Via Benzinga

Wondering what's happening in today's pre-market session? ↗

October 06, 2025

Discover the top movers in Monday's pre-market session and stay informed about market dynamics.

Via Chartmill

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.